Cryptopolitan

Investors grill AI infrastructure and chip stocks, betting on correction ahead

Investors are pushing back hard on stock prices tied to artificial intelligence as doubts rise over how long the frenzy can ...

Tenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M Fundraise - What's Changed

Earlier this week, Tenaya Therapeutics reported encouraging interim data from its RIDGE-1 trial of TN-401 for PKP2-associated ARVC and confirmed that the FDA has lifted the clinical hold on its MyPEAK ...
autoevolution

Custom-Built BMW R 100 Wants to Be a Bobber, Scrambler, and Cafe Racer All at Once

And it manages to pull that combo off rather nicely, while also bringing the classic Beemer’s performance into the modern age ...

How Vaxcyte’s Phase 3 Head-to-Head VAX-31 Trial Could Shape Vaxcyte (PCVX) Investors

Vaxcyte recently began dosing participants in OPUS, its FDA-aligned Phase 3 pivotal noninferiority trial of VAX-31 for preventing invasive pneumococcal disease and pneumonia in adults, enrolling about ...